|
1
|
Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus.
|
Mol Ther
|
2007
|
1.44
|
|
2
|
Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene.
|
Mol Ther
|
2007
|
1.29
|
|
3
|
Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism.
|
J Virol
|
2011
|
1.06
|
|
4
|
Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy.
|
PLoS One
|
2009
|
0.96
|
|
5
|
Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins.
|
Hum Gene Ther
|
2004
|
0.95
|
|
6
|
Signal peptide requirements for lymphocytic choriomeningitis virus glycoprotein C maturation and virus infectivity.
|
J Virol
|
2007
|
0.93
|
|
7
|
Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
|
Clin Cancer Res
|
2007
|
0.86
|
|
8
|
Protein scaffold and expression level determine antiviral activity of membrane-anchored antiviral peptides.
|
Hum Gene Ther
|
2009
|
0.85
|
|
9
|
A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
|
J Gene Med
|
2007
|
0.79
|
|
10
|
Decreased tumor surveillance after adoptive T-cell therapy.
|
Cancer Res
|
2007
|
0.78
|
|
11
|
Measurements of HCV neutralizing antibodies and of HCV-specific CD4+ and CD8+ cells using hepatitis C virus pseudo-particles (HCVpp).
|
J Clin Virol
|
2009
|
0.75
|